Amphastar Pharmaceuticals (AMPH) Prepaid Assets (2013 - 2026)
Amphastar Pharmaceuticals' (AMPH) quarterly Prepaid Assets came in at $11.6 million in Q1 2026, down 34.45% year-on-year from $17.8 million in Q1 2025, and down 11.42% quarter-over-quarter from $13.2 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Prepaid Assets (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Prepaid Assets history runs 14 years deep, the most recent figure standing at $11.6 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 34.45% year-over-year to $11.6 million in Q1 2026; TTM through Mar 2026 was $11.6 million, a 34.45% decrease from a year earlier, with the FY2025 full-year figure at $13.2 million, down 27.79% from the prior year.
- Prepaid Assets retreated to $11.6 million in Q1 2026 per AMPH's latest filing, from $13.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $26.0 million in Q3 2025 and bottomed at $5.9 million in Q2 2023.
- The 5-year median for Prepaid Assets is $8.7 million (2024), against an average of $11.5 million.
- Across the five-year window, Prepaid Assets surged 186.04% in 2024 and tumbled 34.45% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $7.6 million in 2022, then climbed by 19.75% to $9.1 million in 2023, then jumped by 101.1% to $18.2 million in 2024, then fell by 27.79% to $13.2 million in 2025, then dropped by 11.42% to $11.6 million in 2026.
- Per Business Quant, the three latest AMPH Prepaid Assets figures stand at $11.6 million (Q1 2026), $13.2 million (Q4 2025), and $26.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Amphastar Pharmaceuticals | 855.23 Mn | 684.09 Mn | 70.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.65 Mn |
| Dec 31, 2025 | 13.15 Mn |
| Sep 30, 2025 | 26.02 Mn |
| Jun 30, 2025 | 20.33 Mn |
| Mar 31, 2025 | 17.77 Mn |
| Dec 31, 2024 | 18.21 Mn |
| Sep 30, 2024 | 17.72 Mn |
| Jun 30, 2024 | 7.95 Mn |
| Mar 31, 2024 | 8.70 Mn |
| Dec 31, 2023 | 9.06 Mn |
| Sep 30, 2023 | 6.20 Mn |
| Jun 30, 2023 | 5.87 Mn |
| Mar 31, 2023 | 7.33 Mn |
| Dec 31, 2022 | 7.56 Mn |
| Sep 30, 2022 | 5.99 Mn |
| Jun 30, 2022 | 5.90 Mn |
| Mar 31, 2022 | 6.43 Mn |
| Dec 31, 2021 | 7.27 Mn |
| Sep 30, 2021 | 7.76 Mn |
| Jun 30, 2021 | 5.90 Mn |